Chemical Stability of Diclofenac Sodium Injection

Gupta, Vishnu D

A subscription to IJPC includes a print copy delivered by postal mail and on-line access to electronic PDF copies of your subscribed issues.

LEARN MORE

Chemical Stability of Diclofenac Sodium Injection

Author(s): Gupta Vishnu D

Issue: Mar/Apr 2006 - Hospice/Palliative Care
View All Articles in Issue

Page(s): 154-155

Chemical Stability of Diclofenac Sodium Injection Page 1

Chemical Stability of Diclofenac Sodium Injection Page 2

Download in electronic PDF format for $65

Abstract: The stability of diclofenac sodium injection was studied by means of a stability-indicating high-performance liquid chromatography assay method that was developed in our laboratory. There was a direct relationship between the peak heights and the concentrations. The percent relative standard deviation based on five injections was 0.9. The products of decomposition and the excipients present in the dosage form did not interfere with the developed assay method. The injection was stable for at least 23 days when stored in clear glass vials at room temperature. Contrary to the recommendation in the literature, the injection may not be stored at the refrigerated temperature. The physical appearance and the pH value of the injection did not change during the study period.

Related Keywords: Vishnu D. Gupta, PhD, diclofenac sodium, nonsteroidal anti-inflammatory drugs, NSAIDs, stability, HPLC assay, storage temperature

Related Categories: PAIN MANAGEMENT, PEER-REVIEWED, STABILITIES, COMPATIBILITIES

Printer-Friendly Version

Title/Author (Click for Abstract / Details / Purchase)	Issue/Page View/Buy
Related Articles from IJPC
Chemical Stability of Diclofenac Sodium Injection Gupta Vishnu D	Mar/Apr 2006 Pg. 154-155
Pluronic Lecithin Organogel for Local Delivery of Anti-Inflammatory Drugs Frankum James, Ramsay Dale, Das Nandita G, Das Sudip K	Mar/Apr 2004 Pg. 101-105
Stability of Atenolol, Clonazepam, Dexamethasone, Diclofenac Sodium, Diltiazem, Enalapril Maleate, Ketoprofen, Lamotrigine, Penicillamine-D, and Thiamine in SyrSpend SF PH4 Oral Suspensions Polonini HC, Loures S, Lima LC, Ferreira AO, Brandão MA	Mar/Apr 2016 Pg. 167-174
Enhancement of Skin Penetration of Nonsteroidal Anti-Inflammatory Drugs from Extemporaneously Compounded Topical-Gel Formulations Goodwin Donald A, Fuhram L Clifton	Nov/Dec 1999 Pg. 496-500
Mean Kinetic Temperature for Controlled Room Temperature Drug Storage: Official Definitions and Example Calculations Newton David W	Jul/Aug 2019 Pg. 281-287
Diclofenac Sodium 5 mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	Jan/Feb 2021 Pg. 46
Tobramycin Sulfate 0.3% and Diclofenac Sodium 0.1% Ophthalmic Solution Allen Loyd V Jr	Jan/Feb 2010 Pg. 74
Diclofenac Sodium 1%-15% Topical Gel Allen Loyd V Jr	Jan/Feb 2022 Pg. 55
Cyclobenzaprine Hydrochloride 0.5% and Diclofenac Sodium 3% in Pluronic Lecithin Organogel Allen Loyd V Jr	Nov/Dec 2008 Pg. 540
Diclofenac Sodium 10-mg/mL Oral Suspension Allen Loyd V Jr	Jan/Feb 2011 Pg. 64

Particle Measuring Systems - USP <797> Environmental Monitoring Solutions